Early diagnosis of diabetic retinopathy (DR) is of critical importance to suppress severe damage to the retina and/or vision loss. In this study, an optical coherence tomography (OCT)-based computer-aided diagnosis (CAD) method is proposed to detect DR early using structural 3D retinal scans. This system uses prior shape knowledge to automatically segment all retinal layers of the 3D-OCT scans using an adaptive, appearance-based method. After the segmentation step, novel texture features are extracted from the segmented layers of the OCT B-scans volume for DR diagnosis. For every layer, Markov–Gibbs random field (MGRF) model is used to extract the 2nd-order reflectivity. In order to represent the extracted image-derived features, we employ cumulative distribution function (CDF) descriptors. For layer-wise classification in 3D volume, using the extracted Gibbs energy feature, an artificial neural network (ANN) is fed the extracted feature for every layer. Finally, the classification outputs for all twelve layers are fused using a majority voting schema for global subject diagnosis. A cohort of 188 3D-OCT subjects are used for system evaluation using different k-fold validation techniques and different validation metrics. Accuracy of $90.56\%$, $93.11\%$, and $96.88\%$ are achieved using 4-, 5-, and 10-fold cross-validation, respectively. Additional comparison with deep learning networks, which represent the state-of-the-art, documented the promise of our system’s ability to diagnose the DR early.

In developed countries, age-related macular degeneration (AMD), a retinal disease, is the main cause of vision loss in the elderly. Optical Coherence Tomography (OCT) is currently the gold standard for assessing individuals for initial AMD diagnosis. In this paper, we look at how OCT imaging can be used to diagnose AMD. Our main aim is to examine and compare automated computer-aided diagnostic (CAD) systems for diagnosing and grading of AMD. We provide a brief summary, outlining the main aspects of performance assessment and providing a basis for current research in AMD diagnosis. As a result, the only viable alternative is to prevent AMD and stop both this devastating eye condition and unwanted visual impairment. On the other hand, the grading of AMD is very important in order to detect early AMD and prevent patients from reaching advanced AMD disease. In light of this, we explore the remaining issues with automated systems for AMD detection based on OCT imaging, as well as potential directions for diagnosis and monitoring systems based on OCT imaging and telemedicine applications.

This study proposes a novel computer assisted diagnostic (CAD) system for early diagnosis of diabetic retinopathy (DR) using optical coherence tomography (OCT) B-scans. The CAD system is based on fusing novel OCT markers that describe both the morphology/anatomy and the reflectivity of retinal layers to improve DR diagnosis. This system separates retinal layers automatically using a segmentation approach based on an adaptive appearance and their prior shape information. High-order morphological and novel reflectivity markers are extracted from individual segmented layers. Namely, the morphological markers are layerthicknessandtortuositywhile the reflectivity markers are the 1st-order reflectivity of the layer in addition to local and global high-order reflectivity based onMarkov-Gibbs random field (MGRF)andgray-level co-occurrence matrix (GLCM), respectively. The extracted image-derived markers are represented using cumulative distribution function (CDF) descriptors. The constructed CDFs are then described using their statistical measures, i.e., the 10th through 90th percentiles with a 10% increment. For individual layer classification, each extracted descriptor of a given layer is fed to a support vector machine (SVM) classifier with a linear kernel. The results of the four classifiers are then fused using a backpropagation neural network (BNN) to diagnose each retinal layer. For global subject diagnosis, classification outputs (probabilities) of the twelve layers are fused using another BNN to make the final diagnosis of the B-scan. This system is validated and tested on 130 patients, with two scans for both eyes (i.e. 260 OCT images), with a balanced number of normal and DR subjects using different validation metrics:2-folds,4-folds,10-folds, andleave-one-subject-out (LOSO)cross-validation approaches. The performance of the proposed system was evaluated usingsensitivity,specificity,F1-score, andaccuracymetrics. The system’s performance after the fusion of these different markers showed better performance compared with individual markers and other machine learning fusion methods. Namely, it achieved $$96.15\%$$96.15% , $$99.23\%$$99.23% , $$97.66\%$$97.66% , and $$97.69\%$$97.69% , respectively, using the LOSO cross-validation technique. The reported results, based on the integration of morphology and reflectivity markers and by using state-of-the-art machine learning classifications, demonstrate the ability of the proposed system to diagnose the DR early.

Diabetic retinopathy (DR) is a devastating condition caused by progressive changes in the retinal microvasculature. It is a leading cause of retinal blindness in people with diabetes. Long periods of uncontrolled blood sugar levels result in endothelial damage, leading to macular edema, altered retinal permeability, retinal ischemia, and neovascularization. In order to facilitate rapid screening and diagnosing, as well as grading of DR, different retinal modalities are utilized. Typically, a computer-aided diagnostic system (CAD) uses retinal images to aid the ophthalmologists in the diagnosis process. These CAD systems use a combination of machine learning (ML) models (e.g., deep learning (DL) approaches) to speed up the diagnosis and grading of DR. In this way, this survey provides a comprehensive overview of different imaging modalities used with ML/DL approaches in the DR diagnosis process. The four imaging modalities that we focused on are fluorescein angiography, fundus photographs, optical coherence tomography (OCT), and OCT angiography (OCTA). In addition, we discuss limitations of the literature that utilizes such modalities for DR diagnosis. In addition, we introduce research gaps and provide suggested solutions for the researchers to resolve. Lastly, we provide a thorough discussion about the challenges and future directions of the current state-of-the-art DL/ML approaches. We also elaborate on how integrating different imaging modalities with the clinical information and demographic data will lead to promising results for the scientists when diagnosing and grading DR. As a result of this article’s comparative analysis and discussion, it remains necessary to use DL methods over existing ML models to detect DR in multiple modalities.

We propose an automated, explainable artificial intelligence (xAI) system for age-related macular degeneration (AMD) diagnosis. Mimicking the physician's perceptions, the proposed xAI system is capable of deriving clinically meaningful features from optical coherence tomography (OCT) B-scan images to differentiate between a normal retina, different grades of AMD (early, intermediate, geographic atrophy (GA), inactive wet or active neovascular disease [exudative or wet AMD]), and non-AMD diseases. Particularly, we extract retinal OCT-based clinical imaging markers that are correlated with the progression of AMD, which include: ( i ) subretinal tissue, sub-retinal pigment epithelial tissue, intraretinal fluid, subretinal fluid, and choroidal hypertransmission detection using a DeepLabV3+ network; ( ii ) detection of merged retina layers using a novel convolutional neural network model; ( iii ) drusen detection based on 2D curvature analysis; ( iv ) estimation of retinal layers' thickness, and first-order and higher-order reflectivity features. Those clinical features are used to grade a retinal OCT in a hierarchical decision tree process. The first step looks for severe disruption of retinal layers' indicative of advanced AMD. These cases are analyzed further to diagnose GA, inactive wet AMD, active wet AMD, and non-AMD diseases. Less severe cases are analyzed using a different pipeline to identify OCT with AMD-specific pathology, which is graded as intermediate-stage or early-stage AMD. The remainder is classified as either being a normal retina or having other non-AMD pathology. The proposed system in the multi-way classification task, evaluated on 1285 OCT images, achieved 90.82% accuracy. These promising results demonstrated the capability to automatically distinguish between normal eyes and all AMD grades in addition to non-AMD diseases.